Barclays
ACGN

Barclays’s Aceragen Inc ACGN Stock Holding History

Barclays’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-730
Closed -$16K – 5138
2021
Q1 		$16K Buy
+730
New +$54.7K ﹤0.01% 4403
2019
Q3 		– Sell
-2,293
Closed -$104K – 7260
2019
Q2 		$104K Buy
2,293
+1,975
+621% +$93.4K ﹤0.01% 5666
2019
Q1 		$14K Buy
+318
New +$15.4K ﹤0.01% 6472
2018
Q4 		– Sell
-421
Closed -$64K – 7469
2018
Q3 		$64K Buy
421
+99
+31% +$14.1K ﹤0.01% 5916
2018
Q2 		$58K Sell
322
-2,963
-90% -$691K ﹤0.01% 5575
2018
Q1 		$821K Buy
3,285
+3,075
+1,464% +$844K ﹤0.01% 3451
2017
Q4 		$60K Sell
210
-186
-47% -$53.1K ﹤0.01% 5644
2017
Q3 		$120K Buy
396
+395
+39,500% +$103K ﹤0.01% 4802
2017
Q2 		$0 Sell
1
-3
-75% -$784 ﹤0.01% 7024
2017
Q1 		$1K Sell
4
-10
-71% -$2.41K ﹤0.01% 6661
2016
Q4 		$3K Buy
14
+9
+180% +$2.15K ﹤0.01% 6285
2016
Q3 		$2K Buy
+5
New +$1.32K ﹤0.01% 6294
2016
Q2 		– Hold
0
– – – 6718
2016
Q1 		– Hold
0
– – – 6520
2015
Q4 		– Sell
-4
Closed -$1.79K – 6734
2015
Q3 		$1K Sell
4
-9
-69% -$3.98K ﹤0.01% 6636
2015
Q2 		$6K Sell
13
-15
-54% -$6.88K ﹤0.01% 6381
2015
Q1 		$12K Buy
28
+2
+8% +$1.22K ﹤0.01% 6135
2014
Q4 		$14K Sell
26
-256
-91% -$103K ﹤0.01% 6542
2014
Q3 		$76K Sell
282
-246
-47% -$88.5K ﹤0.01% 5555
2014
Q2 		$144K Buy
528
+526
+26,300% +$217K ﹤0.01% 5143
2014
Q1 		$1K Buy
+2
New +$1.37K ﹤0.01% 7505

Other funds holding ACGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

Barclays's ACGN Position: Q2 2021 in Review

Barclays sold out of Aceragen Inc (ACGN) in Q2 2021, closing a stake of 730 shares — an estimated $16K sold.

Barclays first reported a position in ACGN in Q1 2014 and held it in 19 quarters. The position peaked at $821K in Q1 2018. 47 funds tracked by Wall St. Rank hold ACGN as of Q2 2021.

  • Barclays reported no remaining Aceragen Inc position as of Q2 2021 after selling out during the quarter.
  • Barclays sold 730 Aceragen Inc shares in Q2 2021, an estimated $16K.
  • Barclays first reported a position in Aceragen Inc in Q1 2014 and held it in 19 quarters.
  • Barclays's Aceragen Inc position peaked at $821K in Q1 2018.
  • 47 funds tracked by Wall St. Rank held Aceragen Inc as of Q2 2021.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.